The financial crisis and the expected effects on vaccinations in Europe: a literature review

Maltezou, Helena C.; Lionis, Christos

doi:10.3109/23744235.2015.1018315

Cited by 17 publications

(16 citation statements)

References 74 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A study of health care workers in Greece, France, Croatia, and Romania demonstrated the predominance of concerns about vaccine safety [19]. In developed countries in Europe facing financial crisis, health inequalities are expected, with concern that vaccination coverage will decline [20]. Reliable sources of information about immunizations vary by country.…”

Section: Introductionmentioning

confidence: 99%

The impact of access to immunization information on vaccine acceptance in three countries

Handy¹,

Maroudi²,

Powell³

et al. 2017

PLoS ONE

View full text Add to dashboard Cite

IntroductionVaccine acceptance is a critical component of sustainable immunization programs, yet rates of vaccine hesitancy are rising. Increased access to misinformation through media and anti-vaccine advocacy is an important contributor to hesitancy in the United States and other high-income nations with robust immunization programs. Little is known about the content and effect of information sources on attitudes toward vaccination in settings with rapidly changing or unstable immunization programs.ObjectiveThe objective of this study was to explore knowledge and attitudes regarding vaccines and vaccine-preventable diseases among caregivers and immunization providers in Botswana, the Dominican Republic, and Greece and examine how access to information impacts reported vaccine acceptance.MethodsWe conducted 37 focus groups and 14 semi-structured interviews with 96 providers and 153 caregivers in Botswana, the Dominican Republic, and Greece. Focus groups were conducted in Setswana, English, Spanish, or Greek; digitally recorded; and transcribed. Transcripts were translated into English, coded in qualitative data analysis software (NVivo 10, QSR International, Melbourne, Australia), and analyzed for common themes.ResultsDominant themes in all three countries included identification of health care providers or medical literature as the primary source of vaccine information, yet participants reported insufficient communication about vaccines was available. Comments about level of trust in the health care system and government contrasted between sites, with the highest level of trust reported in Botswana but lower levels of trust in Greece.ConclusionsIn Botswana, the Dominican Republic, and Greece, participants expressed reliance on health care providers for information and demonstrated a need for more communication about vaccines. Trust in the government and health care system influenced vaccine acceptance differently in each country, demonstrating the need for country-specific data that focus on vaccine acceptance to fully understand which drivers can be leveraged to improve implementation of immunization programs.

show abstract

Section: Introductionmentioning

confidence: 99%

The impact of access to immunization information on vaccine acceptance in three countries

Handy¹,

Maroudi²,

Powell³

et al. 2017

PLoS ONE

View full text Add to dashboard Cite

show abstract

“…It is likely that mandatory vaccination policies will be increasingly implemented, considering the recent devastating measles epidemics in Europe and the increasing vaccine hesitancy [6,34]. Beyond comprehensive vaccination policies, achievement of high and sustainable vaccination policies requires the successful implementation of additional policy elements, including funding, easy access to vaccines and vaccination services, good monitoring of vaccination rates, and reminding systems [11,20,[35][36][37].…”

Section: Discussionmentioning

confidence: 99%

“…Vaccination of high-risk groups is mandatory only in Serbia and Slovakia and recommended in the remaining countries. The majority of countries (37) issued recommendations for vaccination of residents of long-term care facilities. Lastly all countries except Moldova recommend vaccination for adults of a certain age: for adults >18 years in Austria, Slovenia and Serbia; for adults ≥50 years in Ireland; for adults ≥55 years in Malta and Poland; for adults >59 years in Slovakia; for adults ≥60 years in eight countries (Albania, Germany, Greece, Hungary, Iceland, Netherlands, Russia and Ukraine); and for adults ≥65 years in 26 countries.…”

Section: Seasonal Influenzamentioning

confidence: 99%

Vaccination Programs for Adults in Europe, 2019

et al. 2020

Self Cite

View full text Add to dashboard Cite

Background: While all European countries implement vaccination programs for children, there are gaps in terms of vaccination programs for adults. Methods: We studied the 2019 vaccination policies for adults in 42 European countries. Results: Vaccination programs for adults were in place in all countries. However, there were considerable differences between countries in terms of number of vaccinations, target populations and frame of implementation (recommended or mandatory vaccinations). In particular the following vaccination policies were in place: influenza (42 countries), tetanus (31), diphtheria (30), pneumococcus (29), hepatitis B (20), pertussis (18), measles (14), human papilloma virus (14), meningococcus tetravalent A,C,W,Y (14), rubella (13), hepatitis A (11), mumps (11), poliomyelitis (10), herpes zoster (9), varicella (8), tick-born encephalitis (8), meningococcus B (6), rabies (6), Haemophilus influenzae type b (5), tuberculosis (3), typhoid fever (3), meningococcus C (2), and yellow fever (1). Seventeen countries implement mandatory vaccinations, mainly against diphtheria, tetanus and hepatitis B. Conclusions: There are significant differences in vaccination programs for adults in Europe. Routine vaccination programs for adults need to be strengthened. A consensus-based vaccination program is needed.

show abstract

“…If relatively satisfactory vaccination coverage rates have been achieved in newborns and infants, much remains to be done in adulthood and the elderly in terms of appropriate vaccination coverage 9,19-23 . Adults remain relatively unaware of the benefit of vaccinations 24 .…”

Section: Discussionmentioning

confidence: 99%

“…This is even more manifest since the economic crisis hit Europe in 2008 9 . The actual investment in vaccinations as a whole, which is the cost encompassing the entire vaccine calendar in place in a specific country for its residents, has been rarely addressed in the literature and remains poorly documented even by policy makers.…”

Section: Introductionmentioning

confidence: 99%

The cost of vaccination throughout life: A western European overview

Ethgen

Cornier

Chriv³

et al. 2016

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Despite the interest of policy makers, the actual investment in vaccination is poorly documented. Our study assessed the costs of vaccination throughout life for a fully immunized Western European citizen. National vaccination calendars for England, France, Germany, Italy, Portugal, Spain and Sweden were retrieved. We differentiated men from women and healthy individuals from those suffering from underlying conditions who require specific additional vaccinations. Vaccine costs and administration fees were retrieved from official national source and calculated from the national healthcare perspective. Vaccinating an individual against up to 17 diseases throughout his entire life and in full compliance with national vaccination calendars cost between €328 and €2,352 (vaccines costs only) and between €443 and €3,395 (administration costs included), the lowest range corresponds to a healthy man in Sweden and the highest to a woman with underlying conditions in England. Vaccination costs varied among countries due to heterogeneous national vaccination calendars and organization. In all countries, adults (18–64 y) and elderly (≥65 y) accounted for the lowest vaccines costs compared with infants (0–24 m) and children/adolescents (2–17 y). In comparison, other mass secondary preventive therapies may be at least 3 times more costly. Vaccination requires a relatively low level of investment per individual. Our estimates should be considered to be the maximum potential costs due to our 100% compliance assumption. Increasing coverage rates would bring additional public health benefits for a relatively low incremental cost. A life-course approach of vaccination should also be encouraged because some missed opportunities remain in senior vaccinations.

show abstract

The financial crisis and the expected effects on vaccinations in Europe: a literature review

Cited by 17 publications

References 74 publications

The impact of access to immunization information on vaccine acceptance in three countries

The impact of access to immunization information on vaccine acceptance in three countries

Vaccination Programs for Adults in Europe, 2019

The cost of vaccination throughout life: A western European overview

Contact Info

Product

Resources

About